Though India makes up 16% of the world's population and 20% of the world's disease burden, less than 1.4% of global clinical trials are carried out in the country. Of 236,329 ongoing global clinical studies, only 3,016 studies are being done in India, placing it way behind the USA, Europe, Japan, China, Malaysia and Taiwan, reports. The low number ranks India in the fifth position in Asia.
While clinical trials in South Asia contribute to 3,642 studies, Afghanistan contributes 18, Bangladesh 248, with 2 in Bhutan, 71 in Nepal, 348 in Pakistan and 51 in Sri Lanka, data from the Indian Society for Clinical Research (ISCR) showed. Even as the Indian government is considering rationalising the clinical trial sector and has revised certain guidelines related to providing ancillary care to trial participants by giving 'no fault compensation' for any serious adverse event during clinical…
